Page last updated: 2024-09-04

n-(3,4,5-trichlorophenyl)succinimide and diclofenac

n-(3,4,5-trichlorophenyl)succinimide has been researched along with diclofenac in 1 studies

Compound Research Comparison

Studies
(n-(3,4,5-trichlorophenyl)succinimide)
Trials
(n-(3,4,5-trichlorophenyl)succinimide)
Recent Studies (post-2010)
(n-(3,4,5-trichlorophenyl)succinimide)
Studies
(diclofenac)
Trials
(diclofenac)
Recent Studies (post-2010) (diclofenac)
7028,8741,8743,616

Protein Interaction Comparison

ProteinTaxonomyn-(3,4,5-trichlorophenyl)succinimide (IC50)diclofenac (IC50)
Aldo-keto reductase family 1 member B10Homo sapiens (human)1.9
Prostaglandin G/H synthase 1 Bos taurus (cattle)0.003
Prostaglandin G/H synthase 1Ovis aries (sheep)1.3376
Interleukin-8Homo sapiens (human)0.008
Prostaglandin G/H synthase 1Homo sapiens (human)0.0415
Sodium- and chloride-dependent GABA transporter 1Rattus norvegicus (Norway rat)0.5
C-X-C chemokine receptor type 1Homo sapiens (human)0.012
Sodium- and chloride-dependent GABA transporter 2Rattus norvegicus (Norway rat)0.5
Sodium- and chloride-dependent GABA transporter 3Rattus norvegicus (Norway rat)0.5
Prostaglandin G/H synthase 2Homo sapiens (human)0.4165
Prostaglandin G/H synthase 2 Rattus norvegicus (Norway rat)0.5
Sodium- and chloride-dependent betaine transporterRattus norvegicus (Norway rat)0.5
Prostaglandin G/H synthase 2Ovis aries (sheep)1.6867
Prostaglandin G/H synthase 2Mus musculus (house mouse)0.0502
Solute carrier family 22 member 6Homo sapiens (human)4
Prostaglandin G/H synthase 1 Rattus norvegicus (Norway rat)0.5
P2Y purinoceptor 12Rattus norvegicus (Norway rat)0.02

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdel-Aziz, AA; Asiri, YA; ElTahir, KE1

Other Studies

1 other study(ies) available for n-(3,4,5-trichlorophenyl)succinimide and diclofenac

ArticleYear
Synthesis, anti-inflammatory activity and COX-1/COX-2 inhibition of novel substituted cyclic imides. Part 1: Molecular docking study.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:5

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Crystallography, X-Ray; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Disease Models, Animal; Edema; Hydrogen Bonding; Imides; Male; Models, Molecular; Molecular Structure; Rats; Rats, Sprague-Dawley; Sheep; Stereoisomerism; Structure-Activity Relationship

2011